Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÇϾǰñ¿¡ ¹ß»ýÇÑ °ñÀ°Á¾ÀÇ Ä¡Çè·Ê

CASE REPORTS OF OSTEOSARCOMA IN MANDIBLE

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 1999³â 25±Ç 1È£ p.54 ~ 60
¼Ò¼Ó »ó¼¼Á¤º¸
½Å¿ë±æ/Yong Gil Sin ¹æ¼®ÁØ/ÀÌâÁø/Á¤±âÈÆ/ÀüÀμº/À±±ÔÈ£/Seok Jun Pang/Chang Jin Lee/Ki Hoon Jeong/In Seong Jeon/Kyu Ho Yoon

Abstract

¼­·Ð
°ñÀ°Á¾Àº ¹Ì¼º¼÷ °ñÇü¼º ¼¼Æ÷ ¶Ç´Â ¹Ì¼º¼÷ °£¿±¼¼Æ÷°¡ °ñ¾Æ ¼¼Æ÷·ÎÀÇ ¾Ç¼º ºÐÈ­¿¡ ÀÇÇÏ¿©
°ñ¾ç Á¶Á÷ ¶Ç´Â ¹Ì¼º¼÷°ñÀ» »ý¼ºÇÏ´Â ¾Ç¼ºÁ¾¾çÀ¸·Î ÀÓ»óÀû, Á¶Á÷ÇÐÀû »Ó¸¸ ¾Æ´Ï¶ó ¿¹ÈÄ¿Í
º´ÀÇ ÁøÇà °úÁ¤ µî¿¡ À־ ´Ù¾ç¼ºÀ» º¸ÀÌ´Â °ñ¿¡ ¹ß»ýÇÏ´Â °¡Àå ÈçÇÑ ¾Ç¼ºÁ¾¾çÀÌ´Ù.
Gade´Â ¹Ì±¹¿¡¼­ 100,000¸í´ç 1¸íÀÇ ¹ßº´·üÀ» º¸°íÇÏ¿´À¸¸ç GriswoldµîÀº 1951³â¿¡¼­ 1953
³â¿¡ °ÉÃÄ ³â°£ ³²ÀÚ´Â 100,000 ¸í´ç 1.4¸í, ¿©ÀÚ´Â 100.000 ¸í´ç 1.3¸íÀÇ ¹ßº´·üÀ» º¸°íÇÏ¿´
´Ù. ´ë·« °ñÀ°Á¾ÀÇ 10%°¡ µÎ°æºÎ¿¡ ¹ß»ýÇÏ°í, ¾à6.5%°¡ ¾Ç°ñ¿¡ ¹ß»ýÇϹǷΠ´ë·« ³â°£
100,000¸í´ç 0.07Áõ·ÊÀÇ °ñÀ°Á¾ÀÌ ¾Ç°ñ¿¡ ¹ß»ýÇÑ´Ù°í º¼ ¼ö ÀÖ´Ù. ÁÖ·Î ÀþÀºÀÌÀÇ Àå°ñ¿¡ È£
¹ßÇϸç 40¼¼ ÀÌ»óÀÇ È¯ÀÚ¿¡¼­´Â ÆÄÁ¦Æ®¾¾ º´, ¹æ»ç¼± Ä¡·á, ¼¶À¯¼ºÀÌÇü¼ºÁõ, ¿Ü»ó µî°ú ¿¬°ü
ÇÏ¿© ¹ß»ýÇÑ´Ù. ¹æ»ç¼± ¼Ò°ß»ó osteosclerosing, osteolytic, mixed type µîÀ¸·Î ºÐ·ùÇϸç Á¶
Á÷ÇÐÀû ¼Ò°ß»ó osteoblastic, chondroblastic, fibroblastic µîÀ¸·Î ºÐ·ùÇÑ´Ù. Ä¡·á¹ýÀ¸·Î ±¤¹ü
À§ ÀýÁ¦¼ú, Ç×¾Ï Ä¡·á, ¹æ»ç¼± Ä¡·á¸¦ È¥¿ëÇÏ¸ç ¿¹ÈÄ´Â ºÒ·®ÇÏ¿© 5³â »ýÁ¸À²Àº 20-40% ÀÌ
´Ù.
º»¿ø¿¡¼­´Â 56¼¼ ³²ÀÚ È¯ÀÚ¿Í 22¼¼ ³²ÀÚ È¯ÀÚÀÇ Á¶Á÷ÇÐÀûÀ¸·Î ¼­·Î ´Ù¸¥ typeÀÇ °ñÀ°Á¾À»
¿Ü°úÀû ÀýÁ¦¼ú, Ç×¾Ï Ä¡·á, ¹æ»ç¼±Ä¡·á¸¦ ½ÃÇàÇÏ¿´À¸¸ç ¾ÆÁ÷±îÁö Àç¹ß¼Ò°ß º¸ÀÌÁö ¾Ê¾Ò±â¿¡
¹®Çå °íÂû°ú ÇÔ²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.

Sarcoma is a malignant tumor originated from bone, cartilage, fat tissue, nerve, blood
vessel, bone marrow, endothelium, etc. and for this reason it exhibits considerable
variation not only clinical but histologic appearance.
Osteosarcoma occurs chiefly in young persons and in patients older than 40 years it is
usually associated with Paget's disease, irradiated bone, multiple hereditary exostosis or
polyostotoc fibrous dysplasia and sometimes with preceding trauma. Radiographically it
is divided into three forms: an osteoblastic or sclerosing type, an osteolytic type, and
mixed type.
Histologically it is divided into osteoblastic type, chondroblastic type, fibroblastic type.
The treatment of osteosarcoma is radical excision, combined chemotherapy but the
prognosis is poor and overall 5-year survival rate is 20-40%.
We present two different type sarcomas of 22-year-old male and 56-year-old male
patients which we performed surgical excision, combined chemotherapy and radiation
therapy.

Å°¿öµå

osteosarcoma; surgical excision;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed